Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Overall survival · people with metastatic CRC

It is very uncertain whether FOLFOX + targeted therapy changes overall survival compared with FOLFOX (very low certainty).

1 finding from 1 review

Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
HR 0.92 [0.82, 1.04]
2 studies · 1432 participants
Very low